EUVIMEDEUVIMED entdecken
Crossref

Term Neonatal Outcomes after Maternal Magnesium Sulfate Treatment for Seizure Prophylaxis

Rebecca Chornock, Elissa Trieu, Tetsuya Kawakita iD, Brynley Dean, Rachael Overcash

American Journal of Perinatology · 01.07.2023 · 40 (09) · 923-928

DOI: 10.1055/a-2011-8369 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Perinatology, erschienen am 01.07.2023. Verfasst von Rebecca Chornock und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Maternal-Fetal Medicine, Department of Women's and Infant's Services, MedStar Washington Hospital Center, Washington, District of Columbi…. Hauptthemen laut MEDLINE: Magnesium Sulfate, Lethargy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to evaluate term neonatal outcomes after maternal magnesium sulfate (MgSO4) treatment for seizure prophylaxis. Study Design This was a single-site retrospective cohort study of all women with term singleton gestation requiring MgSO4 treatment for seizure prophylaxis and their respective neonatal outcomes from January 2013 through December 2020. Our primary outcome was neonatal intensive care unit (NICU) admission. We compared outcomes between women treated with MgSO4 for 24 hours or more and women treated with MgSO4 for less than 24 hours prior to delivery. Multivariable logistic regression was performed to calculate adjusted odds ratio (aOR) and 95% confidence interval (95% CI), controlling for variables with a p < 0.05 based on bivariable analysis.

Results

Of 834 women analyzed, 173 (20.7%) neonates were admitted to the NICU. Women treated with MgSO4 for 24 hours or more compared with women treated with MgSO4 for less than 24 hours were more likely to have neonates admitted to the NICU during their hospitalization (27.3 vs. 18.9%; p = 0.01), neonates requiring immediate NICU admission (24.6 vs. 18.3%; p < 0.01), and NICU admission for neonatal lethargy. After adjusting for covariates, only NICU admission due to neonatal lethargy remained statistically significant (aOR: 4.78 [95% CI: 1.50–15.21]).

Conclusion

Prolonged MgSO4 treatment for 24 hours or more was associated with increased odds of term NICU admission due to neonatal lethargy. Key Points

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Magnesium SulfateLethargyInfant, NewbornHumansFemaleRetrospective StudiesHospitalizationSeizures

Substanzen

Magnesium Sulfate

Autor:innen und Institutionen

  • Division of Maternal-Fetal Medicine, Department of Women's and Infant's Services, MedStar Washington Hospital Center, Washington, District of Columbia.
  • Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, Virginia.
  • Georgetown University School of Medicine, Washington, District of Columbia.

ORCID-Profile: Tetsuya Kawakita

Zitieren

APA

Chornock, R., Trieu, E., Kawakita, T., Dean, B., & Overcash, R. (2023). Term Neonatal Outcomes after Maternal Magnesium Sulfate Treatment for Seizure Prophylaxis. American Journal of Perinatology, 40(09), 923-928. https://doi.org/10.1055/a-2011-8369

Vancouver

Chornock R, Trieu E, Kawakita T, Dean B, Overcash R. Term Neonatal Outcomes after Maternal Magnesium Sulfate Treatment for Seizure Prophylaxis. American Journal of Perinatology. 2023;40(09):923-928. doi:10.1055/a-2011-8369

BibTeX
@article{Chornock2023,
  author = {Chornock, Rebecca and Trieu, Elissa and Kawakita, Tetsuya and Dean, Brynley and Overcash, Rachael},
  title = {Term Neonatal Outcomes after Maternal Magnesium Sulfate Treatment for Seizure Prophylaxis},
  journal = {American Journal of Perinatology},
  year = {2023},
  volume = {40},
  number = {09},
  pages = {923--928},
  doi = {10.1055/a-2011-8369}
}
Kostenlos starten →